BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 26555296)

  • 1. Mice null for the deubiquitinase USP18 spontaneously develop leiomyosarcomas.
    Chinyengetere F; Sekula DJ; Lu Y; Giustini AJ; Sanglikar A; Kawakami M; Ma T; Burkett SS; Eisenberg BL; Wells WA; Hoopes PJ; Demicco EG; Lazar AJ; Torres KE; Memoli V; Freemantle SJ; Dmitrovsky E
    BMC Cancer; 2015 Nov; 15():886. PubMed ID: 26555296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of leiomyosarcoma of the uterus in MMTV-CR-1 transgenic mice.
    Strizzi L; Bianco C; Hirota M; Watanabe K; Mancino M; Hamada S; Raafat A; Lawson S; Ebert AD; D'Antonio A; Losito S; Normanno N; Salomon DS
    J Pathol; 2007 Jan; 211(1):36-44. PubMed ID: 17072826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leiomyosarcoma of the uterus: A clinicopathologic, DNA flow cytometric, p53, and mdm-2 analysis of 49 cases.
    Blom R; Guerrieri C; Stâl O; Malmström H; Simonsen E
    Gynecol Oncol; 1998 Jan; 68(1):54-61. PubMed ID: 9454661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uterine leiomyosarcomas are characterized by high p16, p53 and MIB1 expression in comparison with usual leiomyomas, leiomyoma variants and smooth muscle tumours of uncertain malignant potential.
    O'Neill CJ; McBride HA; Connolly LE; McCluggage WG
    Histopathology; 2007 Jun; 50(7):851-8. PubMed ID: 17543074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of bcl-2 expression in leiomyosarcoma of the uterus.
    Zhai YL; Nikaido T; Toki T; Shiozawa A; Orii A; Fujii S
    Br J Cancer; 1999 Jul; 80(10):1658-64. PubMed ID: 10408415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of the c-myc proto-oncogene occurs frequently in uterine sarcomas.
    Jeffers MD; Richmond JA; Macaulay EM
    Mod Pathol; 1995 Sep; 8(7):701-4. PubMed ID: 8539225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular pathogenesis of uterine smooth muscle tumors from transcriptional profiling.
    Quade BJ; Wang TY; Sornberger K; Dal Cin P; Mutter GL; Morton CC
    Genes Chromosomes Cancer; 2004 Jun; 40(2):97-108. PubMed ID: 15101043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An immunohistochemical analysis of stathmin 1 expression in uterine smooth muscle tumors: differential expression in leiomyosarcomas and leiomyomas.
    Allen MM; Douds JJ; Liang SX; Desouki MM; Parkash V; Fadare O
    Int J Clin Exp Pathol; 2015; 8(3):2795-801. PubMed ID: 26045786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential Targets' Analysis Reveals Dual PI3K/mTOR Pathway Inhibition as a Promising Therapeutic Strategy for Uterine Leiomyosarcomas-an ENITEC Group Initiative.
    Cuppens T; Annibali D; Coosemans A; Trovik J; Ter Haar N; Colas E; Garcia-Jimenez A; Van de Vijver K; Kruitwagen RP; Brinkhuis M; Zikan M; Dundr P; Huvila J; Carpén O; Haybaeck J; Moinfar F; Salvesen HB; Stukan M; Mestdagh C; Zweemer RP; Massuger LF; Mallmann MR; Wardelmann E; Mints M; Verbist G; Thomas D; Gommé E; Hermans E; Moerman P; Bosse T; Amant F
    Clin Cancer Res; 2017 Mar; 23(5):1274-1285. PubMed ID: 28232476
    [No Abstract]   [Full Text] [Related]  

  • 10. A mouse model of uterine leiomyosarcoma.
    Politi K; Szabolcs M; Fisher P; Kljuic A; Ludwig T; Efstratiadis A
    Am J Pathol; 2004 Jan; 164(1):325-36. PubMed ID: 14695345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deubiquitinase USP18 Loss Mislocalizes and Destabilizes KRAS in Lung Cancer.
    Mustachio LM; Lu Y; Tafe LJ; Memoli V; Rodriguez-Canales J; Mino B; Villalobos PA; Wistuba I; Katayama H; Hanash SM; Roszik J; Kawakami M; Cho KJ; Hancock JF; Chinyengetere F; Hu S; Liu X; Freemantle SJ; Dmitrovsky E
    Mol Cancer Res; 2017 Jul; 15(7):905-914. PubMed ID: 28242811
    [No Abstract]   [Full Text] [Related]  

  • 12. Loss of ubiquitin-specific peptidase 18 destabilizes 14-3-3ζ protein and represses lung cancer metastasis.
    Chen Z; Zheng L; Chen Y; Liu X; Kawakami M; Mustachio LM; Roszik J; Ferry-Galow KV; Parchment RE; Liu X; Andresson T; Duncan G; Kurie JM; Rodriguez-Canales J; Liu X; Dmitrovsky E
    Cancer Biol Ther; 2022 Dec; 23(1):265-280. PubMed ID: 35387560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Case Report: A Low-grade Uterine Leiomyosarcoma Showing Multiple Genetic Aberrations Including a Bi-allelic Loss of the Retinoblastoma Gene Locus, as well as Germ-line Uniparental Disomy for Part of the Long Arm of Chromosome 22.
    Holzmann C; Koczan D; Loening T; Rommel B; Bullerdiek J
    Anticancer Res; 2017 May; 37(5):2233-2237. PubMed ID: 28476787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated genome analysis of uterine leiomyosarcoma to identify novel driver genes and targetable pathways.
    Cuppens T; Moisse M; Depreeuw J; Annibali D; Colas E; Gil-Moreno A; Huvila J; Carpén O; Zikán M; Matias-Guiu X; Moerman P; Croce S; Lambrechts D; Amant F
    Int J Cancer; 2018 Mar; 142(6):1230-1243. PubMed ID: 29063609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the O-linked N-acetylglucosamine containing epitope H in normal myometrium and uterine smooth muscle cell tumors.
    Sgantzos MN; Galani V; Arvanitis LD; Charchanti A; Psathas P; Nakou M; Havaki S; Kallioras V; Marinos E; Vamvakopoulos NC; Kittas C
    Pathol Res Pract; 2007; 203(1):31-7. PubMed ID: 17129677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allelic loss at the tuberous sclerosis (Tsc2) gene locus in spontaneous uterine leiomyosarcomas and pituitary adenomas in the Eker rat model.
    Kubo Y; Kikuchi Y; Mitani H; Kobayashi E; Kobayashi T; Hino O
    Jpn J Cancer Res; 1995 Sep; 86(9):828-32. PubMed ID: 7591959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromosome aberrations in uterine smooth muscle tumors: potential diagnostic relevance of cytogenetic instability.
    Fletcher JA; Morton CC; Pavelka K; Lage JM
    Cancer Res; 1990 Jul; 50(13):4092-7. PubMed ID: 2354458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ISG15 Deficiency Enhances HIV-1 Infection by Accumulating Misfolded p53.
    Osei Kuffour E; König R; Häussinger D; Schulz WA; Münk C
    mBio; 2019 Aug; 10(4):. PubMed ID: 31455647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ISG15-specific protease USP18 regulates stability of PTEN.
    Mustachio LM; Kawakami M; Lu Y; Rodriguez-Canales J; Mino B; Behrens C; Wistuba I; Bota-Rabassedas N; Yu J; Lee JJ; Roszik J; Zheng L; Liu X; Freemantle SJ; Dmitrovsky E
    Oncotarget; 2017 Jan; 8(1):3-14. PubMed ID: 27980214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Ubiquitin-Specific Peptidase USP18 Promotes Lipolysis, Fatty Acid Oxidation, and Lung Cancer Growth.
    Liu X; Lu Y; Chen Z; Liu X; Hu W; Zheng L; Chen Y; Kurie JM; Shi M; Mustachio LM; Adresson T; Fox S; Roszik J; Kawakami M; Freemantle SJ; Dmitrovsky E
    Mol Cancer Res; 2021 Apr; 19(4):667-677. PubMed ID: 33380466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.